Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 10(3): e0121964, 2015.
Article in English | MEDLINE | ID: mdl-25821969

ABSTRACT

Spinal muscular atrophy (SMA) is a monogenic neurodegenerative disorder subdivided into four different types. Whole genome methylation analysis revealed 40 CpG sites associated with genes that are significantly differentially methylated between SMA patients and healthy individuals of the same age. To investigate the contribution of methylation changes to SMA severity, we compared the methylation level of found CpG sites, designed as "targets", as well as the nearest CpG sites in regulatory regions of ARHGAP22, CDK2AP1, CHML, NCOR2, SLC23A2 and RPL9 in three groups of SMA patients. Of notable interest, compared to type I SMA male patients, the methylation level of a target CpG site and one nearby CpG site belonging to the 5'UTR of SLC23A2 were significantly hypomethylated 19-22% in type III-IV patients. In contrast to type I SMA male patients, type III-IV patients demonstrated a 16% decrease in the methylation levels of a target CpG site, belonging to the 5'UTR of NCOR2. To conclude, this study validates the data of our previous study and confirms significant methylation changes in the SLC23A2 and NCOR2 regulatory regions correlates with SMA severity.


Subject(s)
DNA Methylation/genetics , Nuclear Receptor Co-Repressor 2/genetics , Sodium-Coupled Vitamin C Transporters/genetics , Spinal Muscular Atrophies of Childhood/genetics , 5' Untranslated Regions/genetics , Adolescent , Base Sequence , Case-Control Studies , Child, Preschool , CpG Islands/genetics , Female , Humans , Infant , Male , Molecular Sequence Data
2.
Eur J Hum Genet ; 21(9): 988-93, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23299920

ABSTRACT

Spinal muscular atrophy (SMA) is a monogenic disorder that is subdivided into four different types and caused by survival motor neuron gene 1 (SMN1) deletion. Discordant cases of SMA suggest that there exist additional severity modifying factors, apart from the SMN2 gene copy number. Here we performed the first genome-wide methylation profiling of SMA patients and healthy individuals to study the association of DNA methylation status with the severity of the SMA phenotype. We identified strong significant differences in methylation level between SMA patients and healthy controls in CpG sites close to the genes CHML, ARHGAP22, CYTSB, CDK2AP1 and SLC23A2. Interestingly, the CHML and ARHGAP22 genes are associated with the activity of Rab and Rho GTPases, which are important regulators of vesicle formation, actin dynamics, axonogenesis, processes that could be critical for SMA development. We suggest that epigenetic modifications may influence the severity of SMA and that these novel genetic positions could prove to be valuable biomarkers for the understanding of SMA pathogenesis.


Subject(s)
Epigenesis, Genetic , Muscular Atrophy, Spinal/genetics , rab GTP-Binding Proteins/genetics , rho GTP-Binding Proteins/genetics , Adolescent , Adult , Case-Control Studies , Child , Child, Preschool , CpG Islands , DNA Methylation , Gene Ontology , Genetic Predisposition to Disease , Genome-Wide Association Study , Humans , Infant , Male , Muscular Atrophy, Spinal/pathology , Sequence Analysis, DNA , Young Adult , rab GTP-Binding Proteins/metabolism , rho GTP-Binding Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...